Most companies treat labeling as a final step, something you handle once the product is ready. But in reality, labeling is part of the product itself (and regulators treat it that way).
For medical devices, labeling and packaging are part of design control. For pharmaceuticals, labeling must align precisely with submission strategy, regulatory requirements, and approved claims.
All these pieces work together. When they don’t, the consequences show up quickly:
- Delays due to incomplete or non-compliant labeling
- Rework caused by misalignment with regulatory expectations
- Increased scrutiny during review
- Risk of product misuse due to unclear or incorrect instructions
- Compliance issues tied to missing or improperly presented information















